Fresh Rounds

Alveus Therapeutics, Inc. funding

Alveus Therapeutics, Inc., a pharmaceuticals company based in Philadelphia, PA (founded 2023), filed a Form D with the SEC on January 14, 2026 and reported $56.9M raised of a $111M offering.

Amount raised$56.9M
Offering size$111M
Filed with the SECJanuary 14, 2026
First saleDecember 22, 2025
IndustryPharmaceuticals
SecuritiesEquity
LocationPhiladelphia, PA
Founded2023
Entity typeCorporation
Investors so far17
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania